|
MCFD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.2391999981709E-08 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
1.467230E-01 |
| Stage1-vs-Stage3 |
1.234950E-01 |
| Stage1-vs-Stage4 |
8.004800E-03 |
| Stage2-vs-Stage3 |
1.524100E-02 |
| Stage2-vs-Stage4 |
3.381300E-03 |
| Stage3-vs-Stage4 |
3.188200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.61599999942896E-08 |
| Normal-vs-Asian |
1.70918834641043E-12 |
| Caucasian-vs-AfricanAmerican |
4.035800E-01 |
| Caucasian-vs-Asian |
7.489400E-01 |
| AfricanAmerican-vs-Asian |
5.681600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.243700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.3667000000005E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.465200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.639200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.413400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.862400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.752600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.070600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.898090E-02 |
| Classical-VS-Follicular |
8.977700E-03 |
| Classical-VS-Other |
9.742300E-02 |
| Classical-VS-Normal |
1.62814206561279E-12 |
| Tall-VS-Follicular |
2.001400E-04 |
| Tall-VS-Other |
4.099400E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
5.798500E-03 |
| Follicular-VS-Normal |
1.0858999999197E-07 |
| Other-VS-Normal |
1.2607999999581E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
6.138800E-03 |
|
|
